ABT vs TGT Stock Comparison: Price, Growth & Valuation (2026)
Use MEXC Stock Compare for a detailed ABT vs TGT analysis. Compare ABT and TGT across price performance, growth, valuation, profitability and risk, based on market data and the latest reported financials.
ABT vs TGT Stock Comparison Summary
ABT reported year-over-year revenue growth of 8.1%, compared with 2.0% for TGT. Their P/E ratios are 32.2x and 16.1x, dividend yields are 2.44% and 2.92%, and 30-day volatility levels are 20.4% and 30.4%, respectively. These metrics highlight key differences in growth, valuation, dividend income and market risk. Overall neither stock has a clear lead based on the selected metrics.
Risk Disclaimer: MEXC Stock Compare provides information and comparisons on actual U.S.-listed stocks for reference only. Data may be delayed or inaccurate, does not constitute investment advice, and past performance does not guarantee future results.
ABT vs TGT Stock Return Comparison (1W)
Compare the cumulative total returns of Abbott Laboratories (ABT) and Target Corporation (TGT) over the selected 1W period. Data as of 2026-09-25 12:00:00.
ABT vs TGT Key Equity Metrics Comparison Summary
Abbott Laboratories (ABT) has a market capitalization of $175.63B and operates in the Health Care sector, with its main business classified under Health Care Equipment. Its latest quarterly revenue changed +8.1% year over year.
Target Corporation (TGT) has a market capitalization of $71.31B and operates in the Consumer Staples sector, with its main business classified under Consumer Staples Merchandise Retail. Its latest quarterly revenue changed +2.0% year over year.
ABT vs TGT Key Stock Indicators
| Comparison Metric | ABT | TGT | Comparison results |
Stock Price & Returns Latest delayed stock price with 1-day, 1-month and year-to-date returns. | $101.501D: +0.6%1M: -9.1%1Y: -23.9% | $156.971D: +0.5%1M: -5.4%1Y: +80.1% | TGTWin |
Market Capitalization Total market value of the company's outstanding shares. | $175.63B | $71.31B | ABTWin |
Sector & Industry The company's market sector and primary industry classification. | Health Care / Health Care Equipment | Consumer Staples / Consumer Staples Merchandise Retail | -- |
| Based on delayed market data, ABT is trading at $101.50, compared with $156.97 for TGT. Their market capitalizations are $175.63B and $71.31B, respectively. ABT operates in the Health Care sector, while TGT belongs to Consumer Staples. | |||
| ABT vs TGT Growth & Profitability | |||
Revenue Growth (YoY) Year-over-year change in revenue. | +8.1% | +2.0% | ABTWin |
EPS Growth (YoY) Year-over-year change in earnings per share. | -61.6% | +12.2% | TGTWin |
ROIC Return generated from invested capital. | 10.1% | 17.5% | TGTWin |
Gross Margin / Operating Margin Profitability before and after operating expenses. | 56.6% / 15.8% | 29.3% / 5.6% | ABTWin |
| On growth, ABT posted revenue growth of +8.1% and TTM EPS growth of -61.6%. TGT, by comparison, posted revenue growth of +2.0% and TTM EPS growth of +12.2%.On profitability, ABT recorded a gross margin of 56.6%, an operating margin of 15.8%, and ROIC of 10.1%. For TGT, the corresponding figures were 29.3%, 5.6%, and 17.5%.Overall, the indicators do not show a clear overall leader between the two companies. | |||
| ABT vs TGT Valuation & Balance Sheet | |||
Free Cash Flow Yield Free cash flow as a percentage of market capitalization. | 4.5% | 6.3% | TGTWin |
Net Debt / EBITDA Net debt relative to EBITDA; a negative value indicates net cash. | 0.4x | 1.2x | ABTWin |
Dividend Yield / Payout Ratio Dividend returns relative to share price and the share of earnings paid as dividends. | 2.44% / 78.8% | 2.92% / 47.4% | TGTWin |
| TGT offers a higher free cash flow yield, indicating a less demanding valuation. ABT has the stronger balance sheet, while TGT provides the higher dividend yield. Overall, the two stocks differ mainly in valuation, financial strength and dividend income. | |||
| ABT vs TGT Returns & Risk | |||
Total Return (Dividend-Adjusted) Cumulative return over 1, 5 and 10 years, including dividends. | 1Y: -23.9%5Y: -15.8%10Y: +143.5% | 1Y: +80.1%5Y: -34.2%10Y: +133.5% | ABTWin |
30-Day Realized Volatility Annualized volatility based on the past 30 days of daily returns. | 20.4% | 30.4% | ABTWin |
Beta (5Y vs S&P 500) Sensitivity to market movements; above 1 indicates greater market volatility. | 0.50 | 0.93 | ABTWin |
| ABT has delivered stronger long-term returns, but TGT also shows higher recent volatility and market sensitivity. | |||
ABT vs TGT Valuation & Dividend Metrics
Review ABT compared with TGT across valuation, cash flow and dividend metrics, including P/E, forward P/E, free cash flow yield and dividend yield. These figures are provided for reference only and do not represent a fair-value estimate, price target or investment recommendation.
| Metric | ABT | TGT | Comparison results |
|---|---|---|---|
Market Cap | $175.63B | $71.31B | ABTWin |
P/E (TTM) | 32.2x | 16.1x | TGTWin |
P/S | 3.8x | 0.7x | TGTWin |
EV/EBITDA | 18.8x | 8.8x | TGTWin |
Dividend Yield | 2.44% | 2.92% | TGTWin |
ABT vs TGT Profitability Over Time
Compare ABT and TGT across gross margin and operating margin trends over time to understand how each company's profitability has changed. Based on reported financial data only; not a forecast or investment advice.
| TTM | 3Y Avg | 5Y Avg | 10Y Avg | |
|---|---|---|---|---|
| ABT | 56.4% | 55.7% | 56.0% | 56.5% |
| TGT | 28.1% | 27.1% | 27.8% | 28.6% |
Technical & Fundamental Stock Analysis
RSI (14, daily)
ABT 37.07 • TGT 49.60
Measures short-term price momentum and helps identify possible overbought or oversold conditions.
50/200-DMA Position
ABT 50D Below / 200D Below • TGT 50D Above / 200D Above
Shows whether the stock is trading above or below its medium- and long-term trend lines.
R&D % of Revenue
ABT 6.8% • TGT 0.0%
Shows how much of revenue is invested in research and development.
Share Count Trend (3Y)
ABT Stable • TGT Decreased
Shows whether the company's share count has increased or decreased over the past three years.
Company Profiles
Abbott Laboratories
Health Care Equipment
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Target Corporation
Consumer Staples Merchandise Retail
Target's start dates back to 1962, but now it is one of the largest discount retailers in the United States (where it derives all of its sales), operating just under 2,000 stores and generating over $104 billion in fiscal 2025 sales. The company offers a broad assortment of merchandise across categories including apparel and accessories (16% of fiscal 2025 revenue), beauty and household essentials (30%), food and beverage (24%), hardlines (15%), as well as home furnishings (15%). Target's model is anchored in its physical store base, which fulfills more than 97% of sales. Around 30% of sales are derived from its own private-label brands.
Trade ABT & TGT Stock Futures on MEXC
Trade USDT-margined Stock Futures referencing ABT and TGT on MEXC, with 24/7 access and leverage of up to 10x. These products are derivatives, do not represent ownership of the underlying shares and involve a significant risk of loss.
Everything You Need to Know About ABT vs TGT Stocks
What is MEXC Stock Compare?
MEXC Stock Compare is a side-by-side US stock comparison tool. It helps users compare two companies across stock price performance, market cap, valuation, growth, profitability, balance-sheet strength, dividends and risk. The results are provided for research purposes only and do not constitute investment advice.
Which metrics should I use to evaluate a company's growth?
Start with revenue growth to see how quickly the business is expanding, then review EPS growth to determine whether that growth is translating into higher earnings per share. Gross margin, operating margin and ROIC help assess the quality of that growth by showing profitability and capital efficiency. A company with fast revenue growth but declining margins may be expanding without improving its earnings quality.
How do ABT and TGT compare in growth and profitability?
In the latest reported period, ABT recorded revenue growth of +8.1% and TTM EPS growth of -61.6%, compared with +2.0% and +12.2% for TGT. The indicators do not show a clear overall leader between the two companies. This comparison is based on reported financial metrics and does not predict future performance.
What is the difference between P/E (TTM) and Forward P/E?
P/E (TTM) compares the current share price with actual earnings reported over the past 12 months. Forward P/E uses estimated earnings for the next 12 months, so it reflects market expectations but depends on forecasts that may change. Both ratios should be considered alongside growth, profitability and industry peers.
How do the risk profiles of ABT and TGT compare?
ABT has a 30-day realized volatility of 20.4% and a five-year Beta of 0.50, compared with 30.4% and 0.93 for TGT. TGT shows higher historical volatility and market sensitivity. These indicators describe historical price movements and market sensitivity, but they do not cover every source of investment risk.
What do dividend yield and payout ratio indicate?
Dividend yield shows the annual dividend relative to the current share price, while the payout ratio shows how much of a company's earnings is distributed as dividends. A higher yield may provide more income, but it can also rise because the share price has fallen. Dividend sustainability should therefore be considered together with earnings, cash flow and the payout ratio.
How should I compare a high-growth stock with a lower-valued stock?
A high-growth stock may trade at a higher valuation if investors expect its revenue and earnings to continue expanding. A lower-valued stock may offer a more conservative entry point, but the lower valuation could also reflect slower growth or higher business risk. Growth, valuation, profitability, cash flow and risk should therefore be considered together.
Which is the better stock, ABT or TGT?
There is no single answer for every investor. Growth-focused investors may place greater weight on revenue growth, EPS growth and ROIC, while income-focused investors may prioritize dividend yield and payout sustainability. Investors with lower risk tolerance may focus more on volatility, Beta and balance-sheet strength. MEXC Stock Compare presents the relevant metrics but does not provide a buy or sell recommendation.
Can I trade ABT and TGT as RealStocks on MEXC?
Eligible users can trade ABT and TGT as real US stocks through MEXC RealStocks if both stocks are currently supported. Users must first open and verify a RealStocks account with MEXC's partner licensed broker. RealStocks represents ownership of actual shares rather than tokenized stock exposure. Availability may vary by stock and region, so users should check the corresponding RealStocks trading page before placing an order.
Disclaimer
The stock prices, financial metrics, comparison results and related information displayed on this page are sourced from third-party providers and are provided for informational and educational purposes only. Data may be delayed, incomplete or inaccurate, and MEXC does not guarantee its accuracy, completeness or timeliness. The comparisons and automated summaries do not constitute financial, investment, legal or tax advice, nor a recommendation to buy, sell or hold any security or financial product. Past performance is not indicative of future results. Users should independently verify the information and assess their own objectives, financial circumstances and risk tolerance before making any decision. Where MEXC stock futures or other derivative products are referenced, such products do not represent ownership of the underlying shares and may involve leverage and a substantial risk of loss. Product availability is subject to applicable laws and regional restrictions.